Sorry, you need to enable JavaScript to visit this website.

DEPO-SUBQ PROVERA 104® (medroxyprogesterone acetate injectable suspension) Indications and Usage


Depo-subQ provera 104 is indicated in females of reproductive age for:

  • Prevention of pregnancy and
  • Management of endometriosis-associated pain.

Limitations of Use:

The use of depo-subQ provera 104 is not recommended as a long-term (i.e., longer than 2 years) birth control method or medical therapy for endometriosis-associated pain unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)].

What's New

No Current Announcements.

Contact Pfizer Medical


Please enter your search term(s) for DEPO-SUBQ PROVERA 104®